0.0745	2.8095	OMIM:605432	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	HOXA11	3207
0.2731	1.8696	OMIM:300240	#300240 HOYERAAL-HREIDARSSON SYNDROME; HHS;;CEREBELLAR HYPOPLASIA WITH PANCYTOPENIA;;GROWTH RETARDATION, PRENATAL, WITH PROGRESSIVE PANCYTOPENIA AND CEREBELLARHYPOPLASIA		
0.2731	1.6823	OMIM:273900	THROMBOCYTOPENIA 3		
0.3973	2.4349	DECIPHER:58	LERI-WEILL DYSCHONDROSTOSIS (LWD) - SHOX DELETION		
0.3973	2.2118	OMIM:300367	#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	GATA1	2623
0.3973	2.0488	OMIM:612004	#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	CYCS	54205
0.3973	1.8616	OMIM:614727	#614727 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK; CDG2K;;CDG IIK; CDGIIK	TMEM165	55858
0.3973	1.6017	OMIM:600546	INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY		
0.3973	1.6006	OMIM:615190	#615190 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5; DKCB5	RTEL1	51750
0.4246	1.7618	OMIM:613839	#613839 MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY;;DHFR DEFICIENCY	DHFR	1719
0.4718	4.1974	OMIM:176800	176800 PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF		
0.4718	2.1947	OMIM:313900	THROMBOCYTOPENIA 1	WAS	7454
0.5711	2.0145	OMIM:614200	%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	ITGA2	3673
0.5711	2.0145	OMIM:188000	THROMBOCYTOPENIA 2	ANKRD26, MASTL	22852, 84930
0.5711	1.6425	OMIM:610333	#610333 AICARDI-GOUTIERES SYNDROME 4; AGS4	RNASEH2A	10535
0.6168	2.8356	OMIM:515000	CHLORAMPHENICOL TOXICITY		
0.6168	2.0283	OMIM:601977	#601977 THROMBOCYTHEMIA 2; THCYT2	MPL	4352
0.6168	1.9868	OMIM:614158	614158 BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14;;THROMBOXANE SYNTHETASE DEFICIENCY	TBXAS1	6916
0.6168	1.8819	OMIM:613989	#613989 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2; DKCA2DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4, INCLUDED; DKCB4, INCLUDED		
0.6168	1.8157	OMIM:207300	ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO		
